Prediction: Rigetti's Revenue Passes $50 Million a Year Before 2029

Rigetti's Q2 revenue rose 185% year over year to $5.1 million and first-half revenue reached $9.5 million, supported by a shift toward higher-margin quantum-system sales; gross margin improved 1,200bps to 43%. An $8.4 million order for a 108-qubit system from India is expected to be recognized in Q4, while a U.S. Commerce Department agreement could provide up to $100 million in milestone-based R&D funding. However, Q2 operating loss widened $8.2 million year over year to $28.1 million, and despite $541 million of cash and investments, the stock remains richly valued at roughly $5.2 billion after falling about 74% from its 52-week high.

Analysis

RGTI’s investable issue is not whether revenue can compound from a low base, but whether a project-based hardware vendor can earn enough gross profit to support a research-intensive cost structure without repeated equity issuance. Even at a 50% gross-margin outcome, $50 million of sales would generate only roughly $25 million of gross profit—insufficient against the current R&D run-rate absent material operating leverage. The Commerce funding extends technical runway, but milestone gating and the associated government ownership make it economically closer to subsidized development capital than demand validation.

Near term, the stock is unusually exposed to installation acceptance: a single delayed customer sign-off could create a sharp quarter-to-quarter revenue miss despite no deterioration in long-run backlog. That makes the next delivery update and cash-burn trajectory the 1-3 month catalysts, while evidence of repeat orders, service revenue, and a lower R&D-to-revenue ratio matter over 6-18 months. The key falsifier for the bearish valuation view is multiple independent system orders that establish a repeatable sales cadence rather than national-lab, bespoke transactions.

Consensus may underappreciate that publicly funded quantum deployments can create ecosystem lock-in for HPE’s HPC integration stack, but the dollar contribution is immaterial to HPE’s earnings. Conversely, RGTI’s valuation still embeds a transition from prototype supplier to scaled equipment company before unit economics are demonstrated. High retail ownership and quantum-sector beta make an outright short vulnerable to policy headlines and short squeezes; defined-risk structures are preferable.

Key Decisions for Investors

• Avoid initiating RGTI common ahead of the next major system acceptance; require confirmation of on-time delivery plus at least one incremental commercial order before reassessing a long.
• For a bearish tactical view, use a 3-6 month RGTI put spread rather than stock shorting, sized small: target downside from an acceptance delay, widening operating loss, or milestone-funding slippage; risk is a new federal award, technical milestone, or large sovereign order triggering a squeeze.
• Monitor RGTI quarterly cash use and R&D as a percentage of revenue. A sustained cash-burn rate above roughly $25-30 million per quarter without backlog conversion raises the probability that dilution becomes the next valuation catalyst despite the current cash balance.
• Treat HPE as a watchlist beneficiary rather than a direct trade: upgrade the relevance only if quantum-HPC testbeds translate into recurring integrated-system bookings or management identifies measurable attach revenue; the currently disclosed collaboration is not large enough to move estimates.